Blood cancers, Myeloma
Results
Phase 3
This trial looked at pomalidomide to treat myeloma that had come back or got worse during treatment.
It was for people who had already had lenalidomide and bortezomib.
Recruitment start: 6 November 2012
Recruitment end: 13 November 2014
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Gordon Cook
Celgene Corporation
NIHR Clinical Research Network: Cancer
Last reviewed: 11 Dec 2019
CRUK internal database number: 10644
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
